Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis
暂无分享，去创建一个
W. Hagopian | P. Linsley | J. Dziura | S. Gitelman | K. Herold | P. Gottlieb | C. Greenbaum | P. Preston-Hurlburt | A. Perdigoto | S. A. Long | P. Clark | Kristina M. Harris | A. Woodwyk | K. Harris | the Immune Tolerance Network